MSCI CFO awarded 1,825 shares in equity grant

MSCI Inc. Chief Financial Officer Andrew C. Wiechmann reported an acquisition of 1,825 shares of MSCI common stock on January 30, 2026, at a price of $0 per share.

Rhea-AI Filing Summary

MSCI Inc. Chief Financial Officer Andrew C. Wiechmann reported an acquisition of 1,825 shares of MSCI common stock on January 30, 2026, at a price of $0 per share. This reflects a stock-based compensation award rather than an open-market purchase.

The shares relate to restricted stock units (RSUs) that are expected to vest and convert to stock on the third anniversary of the grant date. The final number of shares issued upon vesting will range from 100% to 130% of the target RSUs, based on a performance metric for MSCI’s 2026 fiscal year. Following this award, Wiechmann beneficially owns 23,464 shares of MSCI common stock directly.

Insider Trade Summary

Grant/Award: 1,825 shares

Grant/Award 1 txn

Insider Wiechmann Andrew C.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,825	$0.00	$0.00

Holdings After Transaction: Common Stock — 23,464 shares (Direct)

Footnotes (1)

1. F1. Restricted stock units ("RSUs") that are expected to vest and convert to shares on the third anniversary of the grant date. The final number of shares issued upon vesting will be between 100% and 130% of the target number of RSUs based on achievement of a performance metric for the for the 2026 fiscal year (January 1, 2026 through December 31, 2026).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MSCI (MSCI) disclose for its CFO?

MSCI disclosed that its CFO, Andrew C. Wiechmann, acquired 1,825 shares of common stock on January 30, 2026. The shares were received at $0 per share as part of an equity compensation award, increasing his directly held stake in MSCI.

How many MSCI shares does CFO Andrew Wiechmann own after this Form 4?

After the reported transaction, CFO Andrew C. Wiechmann beneficially owns 23,464 shares of MSCI common stock. This total reflects the addition of 1,825 shares tied to a restricted stock unit award that was recorded at a price of $0 per share.

What are the key terms of the MSCI RSUs reported in this Form 4?

The filing describes restricted stock units (RSUs) expected to vest and convert to shares on the third anniversary of the grant date. Final shares issued will range from 100% to 130% of the target RSUs, depending on a performance metric for MSCI’s 2026 fiscal year.

How is performance measured for the MSCI RSUs granted to the CFO?

The RSUs’ final payout depends on a performance metric evaluated over MSCI’s 2026 fiscal year, running from January 1, 2026 through December 31, 2026. Based on achievement of this metric, the shares issued will be between 100% and 130% of the target RSU amount.

Did the MSCI CFO pay cash for the 1,825 shares reported?

No. The 1,825 MSCI shares reported were acquired at a price of $0 per share. They arise from a restricted stock unit award, reflecting stock-based compensation rather than a cash-funded purchase in the open market by the CFO.

What is the transaction code used in MSCI CFO Andrew Wiechmann’s Form 4?

The Form 4 uses transaction code “A”, indicating an acquisition of securities. In this case, 1,825 shares of MSCI common stock were acquired at $0 per share, tied to a restricted stock unit award with performance-based vesting terms for the 2026 fiscal year.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wiechmann Andrew C.

(Last) (First) (Middle)

MSCI INC.

7 WORLD TRADE CENTER, 250 GREENWICH ST.

(Street)

NEW YORK NY 10007

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MSCI Inc. [ MSCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/30/2026		A		1,825(1)	A	$0	23,464	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units ("RSUs") that are expected to vest and convert to shares on the third anniversary of the grant date. The final number of shares issued upon vesting will be between 100% and 130% of the target number of RSUs based on achievement of a performance metric for the for the 2026 fiscal year (January 1, 2026 through December 31, 2026).

Remarks:

	/s/ Cecilia Aza, attorney-in-fact	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.